DFX Intelligence
Borrowers
1,057 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Start from
1,057 borrower groups match
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| Hospice Care Buyer, Inc Life sciences | Sponsor not establishedpossible: Brookside Equity Partners LLC (a company of this name is on the sponsor's portfolio page) | 3 | at least $73.3M | 101c | 1 pts | Mar 31, 2028 | Dec 31, 2021 |
| ASP Global Holdings, LLC Distribution | unattributed | 2 | at least $73.2M | 100c | 1 pts | Jul 31, 2029 | Sep 30, 2024 |
| Dental Care Alliance Inc Life sciences | unattributed | 3 | at least $73.1M | 101c | n/a | Jun 1, 2031 | Dec 31, 2021 |
| N••• A••••••••• L•• Healthcare services | unattributed | 3 | at least $72.8M | 99c | 3 pts | Aug 31, 2029 | Sep 30, 2023 |
| N•• H••••• A••••••••• C••• Healthcare services | Sponsor not establishedpossible: L•••• E••••• (a company of this name is on the sponsor's portfolio page) | 8 | at least $72.8M | 101c | 1 pts | Jul 3, 2031 | Sep 30, 2021 |
| E••••••• H•••••• L•• Healthcare services | unattributed | 1 | at least $72.7M | 99c | n/a | Feb 1, 2028 | Dec 31, 2022 |
| B••• C•••• P•••••••• S•••••• C••••••• L•• Healthcare services | unattributed | 3 | at least $72.4M | 101c | 1 pts | Jul 30, 2027 | Dec 31, 2024 |
| R•• S•••••••• I•• Life sciences | unattributed | 7 | at least $71.7M | 100c | 0 pts | Sep 1, 2032 | Dec 31, 2021 |
| E•••••• L•• Life sciences | unattributed | 7 | at least $71.3M | 97c | 0 pts | Sep 14, 2030 | Dec 31, 2021 |
| B•••••• C••••••• H••••••••• I••••••••• L•• Life sciences | C••••••••• C•••••• P•••••••• L•• inferred | 5 | at least $70.4M | 100c | 0 pts | Dec 22, 2031 | Dec 31, 2023 |
| M•• P••••• C••••••••• Healthcare services | unattributed | 6 | at least $69.6M | 101c | 0 pts | Jun 9, 2032 | Dec 31, 2023 |
| C•• P•••••• I•• Life sciences | unattributed | 2 | at least $69.2M | 100c | 0 pts | Dec 7, 2028 | Mar 31, 2024 |
| R••••••••• M••••••• L•• Life sciences | unattributed | 4 | at least $68.9M | 100c | 0 pts | Jun 21, 2027 | Sep 30, 2022 |
| G•••••••• P•••••• L•• Healthcare services | unattributed | 6 | at least $68.4M | 99c | 1 pts | Mar 1, 2032 | Mar 31, 2025 |
| L••••••••• B••••• I•• Healthcare services | Sponsor not establishedpossible: L••••••••• F•••••• (a company of this name is on the sponsor's portfolio page) | 13 | at least $68.2M | 100c | 1 pts | May 1, 2029 | Sep 30, 2022 |
| G•••••• B••••••••• I•• Life sciences | Sponsor not establishedpossible: S• C•••••• P••••••• (a company of this name is on the sponsor's portfolio page) | 1 | at least $67.1M | 100c | n/a | Apr 1, 2029 | Sep 30, 2025 |
| B••••• B••••• I•• Life sciences | unattributed | 9 | at least $67.0M | 100c | 1 pts | Mar 1, 2028 | Sep 30, 2021 |
| S•• C•• B••••• I•• Healthcare services | unattributed | 9 | at least $66.8M | 100c | 0 pts | Dec 1, 2032 | Dec 31, 2024 |
| A••• H••••••• I• L•• Life sciences | unattributed | 4 | at least $66.2M | 72c | 22 pts | Sep 13, 2029 | Dec 31, 2022 |
| E••••••• E•• C••• H••••• L•• Healthcare services | unattributed | 10 | at least $65.8M | 100c | 3 pts | Oct 5, 2029 | Sep 30, 2023 |
| M•••••• G•••• B••••• L•• Healthcare services | unattributed | 2 | at least $65.3M | 100c | 0 pts | Mar 31, 2028 | Jun 30, 2026 |
| S••••• B••••• L•• Healthcare services | unattributed | 6 | at least $65.2M | 100c | 1 pts | Sep 1, 2027 | Sep 30, 2021 |
| D•••• C••• I•••••••• L•• Life sciences | unattributed | 2 | at least $65.2M | 129c | n/a | Oct 4, 2029 | Sep 30, 2024 |
| L• P••••• C•• I•• Life sciences | unattributed | 2 | at least $65.1M | 100c | 0 pts | May 1, 2028 | Jun 30, 2026 |
| B••••• H••••• H•••••••• L•• Life sciences | Sponsor not establishedpossible: A•••••••• I••••••••• M••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 6 | at least $64.8M | 100c | 0 pts | May 1, 2028 | Mar 31, 2024 |
| M•• P•••••••• L• Healthcare services | unattributed | 14 | at least $64.7M | 100c | 0 pts | Apr 1, 2031 | Dec 31, 2021 |
| M••••• A••••••••• L•• Education | unattributed | 2 | at least $64.0M | 100c | 0 pts | Jun 25, 2031 | Jun 30, 2024 |
| B•••••• O•••• L•• Healthcare services | unattributed | 5 | at least $63.9M | 101c | 0 pts | May 31, 2027 | Sep 30, 2022 |
| D•• I••••••••• H•••••••• L•• Healthcare services | unattributed | 20 | at least $63.0M | 101c | n/a | Jun 2, 2031 | Sep 30, 2021 |
| P••••••• P•••••• L•• Healthcare services · Life sciences | Sponsor not establishedcandidates: P•••••• S••••• C••••••• L•; F•••••••• P•••••••• P••• T••• E••••• M••••••••• L• | 6 | at least $61.9M | 95c | 0 pts | Apr 16, 2032 | Dec 31, 2021 |
| B••••••••• L•• Healthcare services | Sponsor not establishedpossible: O•• R••• C•••••• (a company of this name is on the sponsor's portfolio page) | 4 | at least $61.8M | 100c | 1 pts | Dec 14, 2029 | Dec 31, 2022 |
| B••• B•••••• P••••••••• I•• Life sciences | unattributed | 4 | at least $61.6M | 100c | 1 pts | Jan 16, 2033 | Dec 31, 2025 |
| C••• B••••••• L•• Life sciences | unattributed | 9 | at least $61.4M | 100c | 0 pts | Apr 29, 2033 | Sep 30, 2022 |
| R••••• H••••• M••• I•• Education | unattributed | 2 | at least $61.3M | 100c | 0 pts | Sep 30, 2026 | Sep 30, 2022 |
| D••••••• M••••••••• L•• Healthcare services | Sponsor not establishedpossible: H•••••• C•••••• M••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 3 | at least $61.2M | 101c | 1 pts | Apr 21, 2028 | Dec 31, 2021 |
| I•••••• I•• Life sciences | Sponsor not establishedpossible: E•• C••••••• L•• (Form D signer consensus, grade B) | 4 | at least $61.0M | 94c | 33 pts | Jul 17, 2026 | Dec 31, 2021 |
| C••••• H••••• H•••••••• L•• Healthcare services | Sponsor not establishedpossible: H• C•••••• M••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 1 | at least $60.8M | 100c | n/a | Oct 1, 2029 | Mar 31, 2024 |
| C••• M•• B••••• L•• Healthcare services | unattributed | 1 | at least $59.8M | 101c | n/a | Jul 6, 2029 | Sep 30, 2024 |
| S•• E•• C••• H•••••• L•• Life sciences | Sponsor not establishedpossible: M••••••• C•••••• L•• (a company of this name is on the sponsor's portfolio page) | 10 | at least $59.8M | 100c | 1 pts | Oct 5, 2029 | Dec 31, 2022 |
| R•••••• M••••••••• S••••••• L•• Healthcare services | unattributed | 7 | at least $59.6M | 102c | 0 pts | Feb 14, 2029 | Sep 30, 2023 |
| M•••• P••••••••• I•• Life sciences | Sponsor not establishedpossible: C••••••••• C•••••• P•••••••• L•• (Form D signer consensus, grade B) | 7 | at least $59.5M | 100c | 0 pts | Oct 1, 2031 | Dec 31, 2021 |
| E•••••••• P•••••• I•• Healthcare services | unattributed | 7 | at least $59.4M | 102c | 0 pts | Nov 5, 2029 | Dec 31, 2023 |
| C••• H••••• H••••••• C••• Healthcare services | unattributed | 3 | at least $59.1M | 87c | 1 pts | Jun 15, 2027 | Dec 31, 2022 |
| P•• M••••• T•••• L•• Life sciences | unattributed | 5 | at least $58.8M | 99c | 3 pts | Feb 13, 2032 | Mar 31, 2025 |
| T••• S••••• T• I••••••••• L•• Healthcare services | unattributed | 3 | at least $58.3M | 100c | 1 pts | May 4, 2029 | Jun 30, 2023 |
| E••••• I••••••••• I•• Life sciences | unattributed | 4 | at least $57.6M | 99c | n/a | Aug 31, 2027 | Sep 30, 2021 |
| R•••••••• G••••• I•• Life sciences | Sponsor not establishedpossible: O•••• F••• M••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 1 | at least $57.3M | 100c | n/a | Oct 1, 2027 | Dec 31, 2022 |
| T••••••• W••••• H•••••• L•• Healthcare services | unattributed | 4 | at least $57.1M | 102c | 0 pts | Aug 26, 2031 | Sep 30, 2025 |
| F• • M• B•••• L•• Healthcare services | unattributed | 7 | at least $57.1M | 99c | 1 pts | Mar 18, 2032 | Sep 30, 2024 |
| A•••••• H•••••• I•• Life sciences | unattributed | 9 | at least $56.8M | 98c | 1 pts | May 1, 2030 | Dec 31, 2022 |
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.